The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Impact of antibiotics on residual cancer burden and pathologic response rates during neoadjuvant pembrolizumab in breast cancer (BC).

Amit  Kulkarni

No Relationships to Disclose

Patricia  Jewett

No Relationships to Disclose

Anne Hudson  Blaes

No Relationships to Disclose

Douglas  Yee

Stock and Other Ownership Interests  - Apogen Biotechnologies

Honoraria - Daiichi Sankyo; Puma Biotechnology; Tempus

Consulting or Advisory Role - Martell diagnostic

Research Funding - Boehringer Ingelheim

Travel, Accommodations, Expenses - Boehringer Ingelheim